Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function?

By  

Current Drug Targets, Vol. 10, Iss. 9, 2009-09 ,pp. : 863-871

Bentham Science Publishers

Access to resources Recommend Favorite

Preoperative anemia in elective cardiac surgery: prevalence, risk factors, and influence on postoperative outcome

By MUÑOZ MANUEL   ARIZA DANIEL   GÓMEZ-RAMÍREZ SUSANA   HERNÁNDEZ PAULA   GARCÍA-ERCE JOSÉ A.   LEAL-NOVAL SANTIAGO R.  

Transfusion Alternatives in Transfusion Medicine, Vol. 11, Iss. 2, 2010-06 ,pp. : 47-56

Blackwell Publishing

Access to resources Recommend Favorite

Epoetin- in heart surgery patients - not worth the cost?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma

By Fagnoni Philippe   Milpied Noel  

PharmacoEconomics, Vol. 27, Iss. 1, 2009-01 ,pp. : 55-68

Adis International

Access to resources Recommend Favorite

A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD

By Bojke Laura  

PharmacoEconomics, Vol. 25, Iss. 10, 2007-01 ,pp. : 829-841

Adis International

Access to resources Recommend Favorite